Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation

Molecular and Cellular Biology

Volumn 19, Issue 6, 1999, Pages 4431-4442

  Jiménez, Maria J G ^a   Balbín, Milagros ^a   López, José M ^a   Alvarez, Jesús ^a   Komori, Toshihisa ^b   López Otín, Carlos ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; COLLAGENASE 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CBFA 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; EMBRYO; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

EID: 0242655673     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.6.4431     Document Type: Article

References (83)

1. Airola, K., N. Johansson, A. L. Kariniemi, V. M. Kähäri, and U. K. Saarialho-Kere. 1997. Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J. Investig. Dermatol. 109:225-231.
2. Angel, P., I. Baumann, B. Stein, H. Delius, H. J. Rahmsdorf, and P. Herrlich. 1987. 12-O-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. Cell. Biol. 7:2256-2266.
3. Anglard, P., T. Melot, E. Guérin, G. Thomas, and P. Basset. 1995. Structure and promoter characterization of the human stromelysin-3 gene. J. Biol. Chem. 270:20337-20344.
4. Aronson, B. D., A. L. Fisher, K. Blechman, M. Caudy, and J. P. Gergen. 1997. Groucho-dependent and -independent repression activities of Runt domain proteins. Mol. Cell. Biol. 17:5581-5587.
5. Balbín, M., and C. López-Otín. 1996. Hormonal regulation of the human pepsinogen C gene in breast cancer cells: identification of a cis-acting element mediating its induction by androgens, glucocorticoids, and progesterone. J. Biol. Chem. 271:15175-15181.
6. Banerjee, C., S. W. Hiebert, J. L. Stein, J. B. Lian, and G. S. Stein. 1996. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc. Natl. Acad. Sci. USA 93: 4968-4973.
7. Banerjee, C., L. R. McCabe, J. Y. Choi, S. W. Hiebert, J. L. Stein, G. S. Stein, and J. B. Lian. 1997. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J. Cell. Biochem. 64:1-8.
8. Bidwell, J. P., A. J. van Wijnen, E. G. Fey, S. Dworeteky, S. Penman, J. L. Stein, J. B. Lian, and G. S. Stein. 1993. Osteocalcin gene promoter-binding factors are tissue-specific nuclear matrix components. Proc. Natl. Acad. Sci. USA 90:3162-3166.
9. Birkedal-Hansen, H., W. G. Y. Moore, M. K. Bodden, L. J. Windsor, B. Birkedal-Hansen, A. DeCarlo, and J. A. Engler. 1993. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4:197-250.
10. Blavier, L., and J. M. Delaissé. 1995. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J. Cell Sci. 108:3649-3659.
11. Borden, P., D. Solymar, A. Sucharczuk, B. Lindman, P. Cannon, and R. A. Heller. 1996. Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes. J. Biol. Chem. 271:23577-23581.
12. Bruissant, O., and W. Wahli. 1998. A simplified in situ hybridization protocol using non-radioactively labelled probes to detect abundant and rare mRNAs on tissue sections. Biochemica (Boehringer Mannheim) 1:10-16.
13. Cazorla, M., L. Hernández, A. Nadal, M. Balbín, J. M. López, F. Vizoso, P. L. Fernández, K. Iwata, A. Cardesa, C. López-Otín, and E. Campo. 1998. Collagenase-3 overexpression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J. Pathol. 186:144-150.
14. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
15. Ducy, P., and G. Karsenty. 1995. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15:1858-1869.
16. Ducy, P., C. Desbois, B. Boyce, G. Pinero, B. Story, C. Dunstan, E. Smith, J. Bonadio, S. Goldstein, C. Gundberg, A. Bradley, and G. Karsenty. 1996. Increased bone formation in osteocalcin-deficient mice. Nature 382:448-452.
17. Ducy, P., R. Zhang, V. Geoffroy, A. L. Ridall, and G. Karsenty. 1997. Osf2/ Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754.
18. Erlebacher, A., E. H. Filvaroff, S. E. Gitelman, and R. Derynck. 1995. Toward a molecular understanding of skeletal development. Cell 80:371-378.
19. Fosang, A. J., K. Last, V. Knäuper, G. Murphy, and P. J. Neame. 1996. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett. 380:17-20.
20. Franchimont, N., S. Rydziel, A. M. Delany, and E. Canalis. 1997. Interleukin-6 and its soluble receptor cause a marked induction of collagenase-3 expression in rat osteoblast cultures. J. Biol. Chem. 272:12144-12150.
21. Freije, J. P., I. Diez-Itza, M. Balbín, L. M. Sánchez, R. Blasco, J. Tolivia, and C. López-Otín. 1994. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem, 269:16766-16773.
22. Fuller, K., and T. J. Chambers. 1995. Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts. J. Cell Sci. 108:2221-2230.
23. Gack, S., R. Vallon, J. Schmidt, A. Grigoriadis, J. Tuckermann, J. Schenkel, H. Weiher, E. F. Wagner, and P. Angel. 1995. Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes. Cell Growth Differ. 6:759-767.
24. Gutman, A., and B. Wasylyk. 1990. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J. 9:2241-2246.
25. Henney, A. M., P. R. Wakeley, M. J. Davies, K. Foster, R. Hembry, G. Murphy, and S. Humphries. 1991. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. USA 88:8154-8158.
26. Heppner, K. J., L. M. Matrisian, R. A. Jensen, and W. H. Rodgers. 1996. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathol. 149:273-282.
27. Huhtala, P., L. T. Chow, and K. Tryggvason. 1990. Structure of the human type IV collagenase gene. J. Biol. Chem. 265:11077-11082.
28. Huhtala, P., A. Tuuttila, L. T. Chow, J. Lohi, J. Keski-Oja, and K. Tryggvason. 1991. Complete structure of the human gene for 92-kDa type IV collagenase: divergent regulation of expression for the 92- and 72-kDa enzyme genes in HT-1080 cells. J. Biol. Chem. 266:16485-16490.
29. Johansson, N., K. Airola, R. Grénman, A. L. Kariniemi, U. Saarialho-Kere, and V. K. Kähäri. 1997. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am. J. Pathol. 151:499-508.
30. Johansson, N., U. Saarialho-Kere, K. Airola, R. Herva, L. Nissinen, J. Westermarck, E. Vuorio, J. Heino, and V. M. Kähäri. 1997. Collagenase-3 is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during fetal bone development. Dev. Dyn. 208:387-397.
31. Jones, J. I., and D. R. Clemmons. 1995. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev. 16:3-34.
32. Kagoshima, H., K. Shigesada, M. Satake, Y. Ito, H. Miyoshi, M. Ohki, M. Pepling, and P. Gergen. 1993. The Runt domain identifies a new family of heteromeric transcriptional regulators. Trends Genet. 9:338-341.
33. Knäuper, V., C. López-Otín, B. Smith, G. Knight, and G. Murphy. 1996. Biochemical characterization of human collagenase-3. J. Biol. Chem. 271: 1544-1550.
34. Knäuper, V., H. Will, C. López-Otín, B. Smith, S. J. Atkinson, H. Stanton, R. Hembry, and G. Murphy. 1996. Cellular mechanisms for human procollagenase-3 (MMP-13) activation: evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J. Biol. Chem. 271:17124-17131.
35. Knäuper, V., S. Cowell, B. Smith, C. López-Otín, M. O'Shea, H. Morris, L. Zardi, and G. Murphy. 1997. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J. Biol. Chem. 272:17124-17131.
36. Knäuper, V., B. Smith, C. López-Otín, and G. Murphy. 1997. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur. J. Biochem. 248:369-373.
37. Komori, T., H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R. T. Bronson, Y. H. Gao, M. Inada, M. Sato, R. Okamoto, Y. Kitamura, S. Yoshiki, and T. Kishimoto. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
38. Komori, T. Unpublished results.
39. Kusano, K., C. Miyaura, M. Inada, T. Tamura, A. Ito, H. Nagase, K. Kamoi, and T. Suda. 1998. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 139:1338-1345.
40. Lee, B., K. Thirunavukkarasu, L. Zhou, L. Pastore, A. Baldini, J. Hecht, V. Geoffroy, P. Ducy, and G. Karsenty. 1997. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat. Genet. 16:307-310.
41. Lindy, O., Y. T. Konttinen, T. Sorsa, Y. Ding, S. Santavirta, A. Ceponis, and C. López-Otín. 1997. MMP-13 (collagenase-3) in human rheumatoid synovium. Arthritis Rheum. 40:1391-1399.
42. Lu, J., M. Maruyama, M. Satake, S. C. Bae, E. Ogawa, H. Kagoshima, K. Shigesada, and Y. Ito. 1995. Subcellular localization of the α and β subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF. Mol. Cell. Biol. 15:1651-1661.
43. MacDougall, J. R., and L. M. Matrisian. 1995. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14:351-362.
44. Matrisian, L. M. 1992. The matrix degrading metalloproteinases. Bioessays 14:455-463.
45. Mattot, V., M. B. Raes, P. Henriet, Y. Eeckhout, D. Stehelin, B. Vandenbunder, and X. Desbiens. 1995. Expression of interstitial collagenase is restricted to skeletal tissue during mouse embryogenesis. J. Cell Sci. 108: 529-535.
46. Meikle, M. C., S. Bord, R. M. Hembry, and J. J. Reynolds. 1995. The synthesis of collagenase, gelatinase-A (72 kDa) and -B (92 kDa), and TIMP-1 and -2 by human osteoblast from normal and arthritic bone. Bone 17:255-260.
47. Merriman, H. L., A. J. van Wijnen, S. Hiebert, J. P. Bidwell, E. Fey, J. Lian, J. Stein, and G. S. Stein. 1995. The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry 34:13125-13132.
48. Meyers, S., J. R. Downing, and S. W. Hiebert. 1993. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol. Cell. Biol. 13:6336-6345.
49. Mitchell, P. G., H. A. Magna, L. M. Reeves, L. L. Lopresti-Morrow, S. A. Yocum, P. J. Rosner, K. F. Geoghegan, and J. E. Hambor. 1996. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Investig. 97:761-768.
50. 3 integrin stimulates inmediate cell signals in osteoblasts. J. Biol. Chem. 266: 20369-20374.
51. Mundlos, S., F. Otto, C. Mundlos, J. B. Mulliken, A. S. Aylsworth, S. Albright, D. Lindhout, W. G. Cole, W. Henn, J. H. M. Knoll, M. J. Owen, R. Mertelsmann, B. U. Zabel, and B. R. Olsen. 1997. Mutations involving the transcription factor Cbfa1 cause cleidocranial dysplasia. Cell 89:773-779.
52. Murphy, G., and R. M. Hembry. 1992. The matrix metalloproteinases and their inhibitors. J. Rheumatol. 19:61-64.
53. Otto, F., A. P. Thornell, T. Crompton, A. Denzel, K. C. Gilmour, I. R. Rosewell, G. W. H. Stamp, R. S. P. Beddington, S. Mundlos, B. R. Olsen, P. B. Selby, and M. J. Owen. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
54. Partridge, N., H. W. Walling, S. R. Bloch, T. H. Omura, P. T. Chan, A. T. Pearman, and W. Y. Chou. 1996. The regulation and regulatory role of collagenase in bone. Crit. Rev. Eukaryot. Gene Expr. 6:15-27.
55. Pendás, A. M., T. Matilla, X. Estivill, and C. López-Otín. 1995. The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family. Genomics 26: 615-618.
56. Pendás, A. M., M. Balbín, E. Llano, M. G. Jiménez, and C. López-Otín. 1997. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP-13). Genomics 40:222-233.
57. Rajakumar, R. A., and C. O. Quinn. 1996. Parathyroid hormone induction of rat interstitial collagenase mRNA in osteosarcoma cells is mediated through an AP-1 binding site. Mol. Endocrinol. 10:867-878.
58. Rantakokko, J., H. T. Aro, M. Savontaus, and E. Vuorio. 1996. Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett. 393:307-313.
59. Reboul, P., J. P. Pelletier, G. Tardif, J. M. Cloutier, and J. Martel-Pelletier. 996. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. J. Clin. Investig. 97:2011-2019.
60. Reinholt, F. P., K. Hultenby, A. Olberg, and D. Heinegard. 1990. Osteopontin: a possible anchor of osteoclasts to bone. Proc. Natl. Acad. Sci. USA 87:4473-4475.
61. Reponen, P., C. Sahlberg, C. Munaut, I. Thesleff, and K. Tryggvason. 1994. High expression of 92 kDa type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J. Cell Biol. 124:1091-1102.
62. Roach, H. I., J. Erenpreisa, and T. Aigner. 1995. Osteogenic differentiation of hypertrophic chondrocytes involves asymmetric cell divisions and apoptosis. J. Cell Biol. 131:483-494.
63. Sakamoto, S., and M. Sakamoto. 1982. Biochemical and immunohistochemical studies on collagenase in resorbing bone in tissue culture. J. Periodontal Res. 17:523-526.
64. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
65. Schorpp, M., M. G. Mattei, I. Herr, S. Gack, J. Schaper, and P. Angel. 1995. Structural organization and chromosomal localization of the mouse collagenase type I gene. Biochem. J. 308:211-217.
66. Schreiber, E., P. Matthias, M. M. Müller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini extracts" prepared from a small number of cells. Nucleic Acids Res. 17:6419.
67. Selvamurugan, N., W. Y. Chou, A. T. Pearman, M. R. Pulumati, and N. C. Partridge. 1998. Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence. J. Biol. Chem. 273:10647-10657.
68. Sirum, K. L., and C. E. Brinckerhoff. 1989. Cloning of the genes for human stromelysin and stromelysin 2: differential expression in rheumatoid synovial fibroblasts. Biochemistry 28:8691-8698.
69. Speck, N. A., and T. Stacy. 1995. A new transcription factor family associated with human leukemias. Crit. Rev. Eukaryot. Gene Expr. 5:337-364.
70. Stahle-Bäckdahl, M., B. Sandsted, K. Bruce, A. Lindahl, M. G. Jiménez, J. A. Vega, and C. López-Otín. 1997. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab. Investig. 76:717-728.
71. Stein, G. S., J. B. Lian, J. L. Stein, A. J. van Wijnen, and M. Montecino. 1996. Transcriptional control of osteoblast growth and differentiation. Physiol. Rev. 76:593-629.
72. Stetler-Stevenson, W. G., S. Aznavoorian, and L. A. Liotta. 1993. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9:541-573.
73. Stewart, M., A. Terry, M. Hu, M. O'Hara, K. Blyth, E. Baxter, E. Cameron, D. E. Onions, and J. C. Neil. 1997. Proviral insertions induce the expression of bone-specific isoforms of PEBP2αA (CBFA1): evidence for a new myc collaborating oncogene. Proc. Natl. Acad. Sci. USA 94:8646-8651.
74. Thirunavukkarasu, K., M. Mahajan, K. W. McLarren, S. Stifani, and G. Karsenty. 1998. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfβ. Mol. Cell. Biol. 18:4197-4208.
75. Thrailkill, K. M., L. D. Quarles, H. Nagase, K. Suzuki, D. M. Serra, and J. L. Fowlkes. 1995. Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology 136:3527-3533.
76. Uría, J. A., M. Stahle-Bäckdahl, M. Seiki, A. Fueyo, and C. López-Otín. 1997. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res. 57:4882-4888.
77. Uría, J. A., M. Balbín, J. M. López, J. Álvarez, F. Vizoso, M. Takigawa, and C. López-Otín. 1998. Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am. J. Pathol. 153:91-101.
78. Uría, J. A., M. G. Jiménez, M. Balbín, J. M. P. Freije, and C. López-Otín. 1998. Differential effects of TGF-β on the expression of collagenase-1 and collagenase-3 in human fibroblasts. J. Biol. Chem. 273:9769-9777.
79. Vincenti, M. P., C. I. Coon, J. A. Mengshol, S. Yocum, P. Mitchell, and C. E. Brinckerhoff. 1998. Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1). Biochem. J. 331:341-346.
80. Vu, T. H., J. M. Shipley, G. Bergers, J. E. Beger, J. A. Helms, D. Hanahan, S. D. Shapiro, R. M. Senior, and Z. Werb. 1998. Matrix metalloproteinase gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411-422.
81. Werb, Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91:439-442.
82. Whitelock, J. M., A. D. Murdoch, R. V. Iozzo, and P. A. Underwood. 1996. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J. Biol. Chem. 271:10079-10086.
83. Xiao, Z. S., R. Thomas, T. K. Hinson, and L. D. Quarles. 1998. Genomic structure and isoform expression of the mouse, rat, and human Cbfa1/Osf2 transcription factor. Gene 214:187-197.